| 2026-06-12 17:05 |
8-K |
["3.01", "8.01"] |
other |
0.02
|
Nasdaq delisting notice due to sub-$1.00 bid price; no M&A signals present. |
SEC · detail |
| 2026-05-26 08:03 |
8-K |
["8.01"] |
other |
0.05
|
Clinical trial results announcement for gene therapy; no M&A, activist, or strategic transaction signals. |
SEC · detail |
| 2026-05-14 08:05 |
8-K |
["8.01"] |
other |
0.05
|
8-K Item 8.01 announces positive preclinical data on diabetes gene therapy; no M&A signals. |
SEC · detail |
| 2026-04-30 08:00 |
8-K |
["8.01", "9.01"] |
other |
0.05
|
Patent grant announcement for REQORSA gene therapy; no M&A signals present. |
SEC · detail |
| 2026-04-28 07:07 |
8-K |
["8.01"] |
other |
0.05
|
Press release announcing preclinical diabetes gene therapy data presentation; no M&A signals detected. |
SEC · detail |